Astera Labs, Inc. $ALAB Shares Acquired by Ethic Inc.

Ethic Inc. lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 234.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,811 shares of the company’s stock after purchasing an additional 11,077 shares during the period. Ethic Inc.’s holdings in Astera Labs were worth $1,439,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Astera Labs during the second quarter worth $29,000. Bernard Wealth Management Corp. acquired a new position in shares of Astera Labs during the second quarter worth $36,000. GAMMA Investing LLC lifted its position in shares of Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after purchasing an additional 284 shares in the last quarter. Harbour Investments Inc. lifted its position in shares of Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after purchasing an additional 619 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Astera Labs during the first quarter worth $48,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on ALAB shares. Jefferies Financial Group boosted their target price on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Citigroup lifted their price target on shares of Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Cowen assumed coverage on shares of Astera Labs in a research note on Tuesday, September 30th. They issued a “hold” rating for the company. Finally, Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Sunday. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $162.06.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 152,517 shares of the company’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the sale, the chief executive officer owned 450,001 shares of the company’s stock, valued at $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 0.8%

Shares of NASDAQ:ALAB opened at $164.97 on Friday. The company has a fifty day simple moving average of $196.79 and a 200 day simple moving average of $131.95. The firm has a market cap of $27.42 billion, a PE ratio of 294.59, a price-to-earnings-growth ratio of 4.11 and a beta of 1.43. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The firm’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.